©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 110698
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110698
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110698
Table 5 Correlation of cytokeratin 18 fragment with clinical factors: Clinical factors
| Factors | Total protein | AST | ALT | AST/ALT | γ-glutamyl transpeptidase | Ferritin | TG | HDL | TG/HDL | Hemoglobin A1c | |
| Cytokeratin 18 fragment | R | 0.1467 | 0.4822 | 0.2819 | −0.1157 | 0.1511 | 0.3288 | 0.5594 | −0.2406 | 0.5966 | 0.1983 |
| n | 123 | 123 | 123 | 123 | 123 | 108 | 123 | 123 | 123 | 119 | |
| P value | 0.10258 | < 0.00001 | 0.00145 | 0.19886 | 0.09258 | 0.00045 | < 0.00001 | 0.00689 | < 0.00001 | 0.02923 |
- Citation: Ichikawa T, Miuma S, Yamashima M, Yamamichi S, Koike M, Nakano Y, Yajima H, Miyazaki O, Ikeda T, Okamura T, Komatsu N, Yoshino M, Miyaaki H. Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease. World J Hepatol 2025; 17(11): 110698
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/110698.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.110698